TRIPLE ORAL ANTIDIABETIC OR METFORMIN-BASAL INSULIN COMBINATION: TESTING TWO DIFFERENT APPROACHES OF CONSENSUS ALGORITHM IN ADJUSTING ANTIDIABETIC THERAPY. AN OPEN-LABEL, RANDOMIZED STUDY

MESCİ, BANU; OĞUZ, AYTEKİN; Çoksert Kılıç, Damla; Çelik, Selda; Şahin, Güler; Tekin, Murat; Sarıışık, Ahmet; Köroğlu, Gülsüm; Sağun, Gül; Takır, Mümtaz; Tamer, Gonca

doi:10.4183/aeb.2012.587

TRIPLE ORAL ANTIDIABETIC OR METFORMIN-BASAL INSULIN COMBINATION: TESTING TWO DIFFERENT APPROACHES OF CONSENSUS ALGORITHM IN ADJUSTING ANTIDIABETIC THERAPY. AN OPEN-LABEL, RANDOMIZED STUDY

Atıf İçin Kopyala

MESCİ B. , OĞUZ A. , Çoksert Kılıç D., Çelik S., Şahin G., Tekin M., et al.

ACTA ENDOCRINOLOGICA-BUCHAREST, cilt.8, ss.587-594, 2012 (SCI İndekslerine Giren Dergi)

Cilt numarası: 8 Konu: 4
Basım Tarihi: 2012
Doi Numarası: 10.4183/aeb.2012.587
Dergi Adı: ACTA ENDOCRINOLOGICA-BUCHAREST
Sayfa Sayısı: ss.587-594

Özet

Objective. The aim of this study was to compare the clinical effects of a triple oral antidiabetic combination versus basal insulin and metformin combination treatment in patients with poorly controlled type 2 diabetes.